First description of clinical Aspergillus fumigatus cyp51A TR46/Y121F/T289A mutant in Portugal

J Glob Antimicrob Resist. 2018 Jun:13:190-191. doi: 10.1016/j.jgar.2018.04.016. Epub 2018 May 7.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antifungal Agents / pharmacology
  • Aspergillosis / microbiology
  • Aspergillus fumigatus / drug effects
  • Aspergillus fumigatus / genetics*
  • Aspergillus fumigatus / isolation & purification
  • Azoles / pharmacology
  • Drug Resistance, Multiple, Fungal*
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Mutation*
  • Portugal
  • Retrospective Studies

Substances

  • Antifungal Agents
  • Azoles